Phenylalanine monooxygenase and the ‘sulfoxidation polymorphism’; the salient points
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:37 |
|---|---|
| Enthalten in: |
Drug metabolism and personalized therapy - 37(2022), 4 vom: 17. Juni, Seite 393-395 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Steventon, Glyn B. [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| BKL: |
|---|
| Anmerkungen: |
© 2022 the author(s), published by De Gruyter, Berlin/Boston |
|---|
| doi: |
10.1515/dmpt-2021-0233 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
GRUY008685479 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | GRUY008685479 | ||
| 003 | DE-627 | ||
| 005 | 20230813110201.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230813s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1515/dmpt-2021-0233 |2 doi | |
| 035 | |a (DE-627)GRUY008685479 | ||
| 035 | |a (DE-B1597)dmpt-2021-0233-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.40 |2 bkl | ||
| 100 | 1 | |a Steventon, Glyn B. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Phenylalanine monooxygenase and the ‘sulfoxidation polymorphism’; the salient points |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © 2022 the author(s), published by De Gruyter, Berlin/Boston | ||
| 700 | 1 | |a Mitchell, Stephen C. |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Drug metabolism and personalized therapy |d De Gruyter, 2015 |g 37(2022), 4 vom: 17. Juni, Seite 393-395 |h Online-Ressource |w (DE-627)GRUY00052929X |w (DE-600)2822040-7 |w (DE-576)433099526 |x 2363-8915 |7 nnns |
| 773 | 1 | 8 | |g volume:37 |g year:2022 |g number:4 |g day:17 |g month:06 |g pages:393-395 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1515/dmpt-2021-0233 |z kostenfrei |3 Volltext |
| 912 | |a GBV_GRUY | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OPC-PHA | ||
| 936 | b | k | |a 44.40 |j Pharmazie |j Pharmazeutika |q VZ |
| 951 | |a AR | ||
| 952 | |d 37 |j 2022 |e 4 |b 17 |c 06 |h 393-395 | ||